[Therapy with daunomycin in chronic lymphoproliferative diseases].
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000209:etiology; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy
D000477:Alkylating Agents; D011241:Prednisone; D003630:Daunorubicin
Terapia con daunomicina nelle malattie linforproliferative croniche.